A roundup and what we learned from Collier, Lee and LaBelle football teams from games played Sept. 24-25, 2026 in Fort Myers, ...
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...
Viking Therapeutics (VKTX) added more than 30% in the premarket on Tuesday after disclosing that its GLP-1/GIP receptor agonist VK2735 delivered 22% weight loss and showed potential in maintaining ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Notes: 1) Safety population, includes all randomized subjects who received at least one dose of study drug on or after Week 21. 2) Subjects treated with VK2735 were titrated to final doses as ...
Add Yahoo as a preferred source to see more of our stories on Google. Days after the announcement of Denmark's largest-ever Viking Age silver hoard discovery (and months after Norway's largest find), ...
Viking stock catapulted Tuesday on "stellar" test results for its weight-loss shot, sending shares of rival Novo (NVO) lower. The study examined a every-other-week and monthly doses of Viking ...
Days after the announcement of Denmark’s largest-ever Viking Age silver hoard discovery (and months after Norway’s largest find), comes a fresh discovery out of Finland. At about 10 pounds, the find ...
22% Placebo-Adjusted Weight Loss Reported at Week 33 Following Weekly Dosing of VK2735 at 17.5 mg; No Plateau Observed Results Demonstrate Viability of Monthly and Every Other Week Dosing Regimens for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results